{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:44:40Z","timestamp":1768704280895,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10637-021-01186-3","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T07:02:31Z","timestamp":1632553351000},"page":"389-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Relapsing polychondritis after treatment with PD-1 blockade"],"prefix":"10.1007","volume":"40","author":[{"given":"Tatsuya","family":"Ogimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyohiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"issue":"2","key":"1186_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7326\/0003-4819-129-2-199807150-00011","volume":"129","author":"DE Trentham","year":"1998","unstructured":"Trentham DE, Le CH (1998) Relapsing polychondritis. Ann Intern Med 129(2):114\u2013122. https:\/\/doi.org\/10.7326\/0003-4819-129-2-199807150-00011","journal-title":"Ann Intern Med"},{"issue":"3","key":"1186_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","volume":"55","author":"LP McAdam","year":"1976","unstructured":"McAdam LP, O\u2019Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55(3):193\u2013215","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1186_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","volume":"89","author":"JM Damiani","year":"1979","unstructured":"Damiani JM, Levine HL (1979) Relapsing polychondritis\u2013report of ten cases. Laryngoscope 89(6):929\u2013946","journal-title":"Laryngoscope"},{"key":"1186_CR4","doi-asserted-by":"publisher","unstructured":"Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM (1986) Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 104(1):74\u201378. https:\/\/doi.org\/10.7326\/0003-4819-104-1-74","DOI":"10.7326\/0003-4819-104-1-74"},{"issue":"1","key":"1186_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/kez243","volume":"59","author":"A Sharma","year":"2020","unstructured":"Sharma A, Kumar R, Mb A, Naidu G, Sharma V, Sood A, Dhir V, Verma R, Singh H, Bhattacharya A, Jain S, Mittal BR (2020) Fluorodeoxyglucose positron emission tomography\/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis. Rheumatology (Oxford) 59(1):99\u2013106. https:\/\/doi.org\/10.1093\/rheumatology\/kez243","journal-title":"Rheumatology (Oxford)"},{"issue":"1057","key":"1186_CR6","doi-asserted-by":"publisher","first-page":"20150695","DOI":"10.1259\/bjr.20150695","volume":"89","author":"W Lei","year":"2016","unstructured":"Lei W, Zeng H, Zeng DX, Zhang B, Zhu YH, Jiang JH, Huang JA (2016) (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis. Br J Radiol 89(1057):20150695. https:\/\/doi.org\/10.1259\/bjr.20150695","journal-title":"Br J Radiol"},{"issue":"2","key":"1186_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1440-1843.2008.01455.x","volume":"14","author":"T Tsuburai","year":"2009","unstructured":"Tsuburai T, Suzuki M, Tsurikisawa N, Ono E, Oshikata C, Taniguchi M, Akiyama K (2009) Use of inhaled fluticasone propionate to control respiratory manifestations of relapsing polychondritis. Respirology 14(2):299\u2013301. https:\/\/doi.org\/10.1111\/j.1440-1843.2008.01455.x","journal-title":"Respirology"},{"issue":"11","key":"1186_CR8","doi-asserted-by":"publisher","first-page":"E43","DOI":"10.1002\/hed.26456","volume":"42","author":"K Kuba","year":"2020","unstructured":"Kuba K, Nakahira M, Inoue H, Kogashiwa Y, Ebihara Y, Sugasawa M (2020) Nivolumab-related tracheobronchial chondritis: extremely rare manifestation of an immune-related adverse effect. Head Neck 42(11):E43\u2013E48. https:\/\/doi.org\/10.1002\/hed.26456","journal-title":"Head Neck"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-021-01186-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-021-01186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:40:19Z","timestamp":1678509619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-021-01186-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1007\/s10637-021-01186-3","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"17 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent to participate was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}